1478 related articles for article (PubMed ID: 19089938)
21. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
[TBL] [Abstract][Full Text] [Related]
22. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
[TBL] [Abstract][Full Text] [Related]
23. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.
Bair TL; Muhlestein JB; May HT; Meredith KG; Horne BD; Pearson RR; Li Q; Jensen KR; Anderson JL; Lappé DL
Circulation; 2007 Sep; 116(11 Suppl):I226-31. PubMed ID: 17846308
[TBL] [Abstract][Full Text] [Related]
24. Multivessel coronary drug-eluting stenting alone in patients with significant ischemic mitral regurgitation: a 4-year follow up.
Ho PC; Nguyen ME
J Invasive Cardiol; 2008 Jan; 20(1):41-3. PubMed ID: 18174619
[TBL] [Abstract][Full Text] [Related]
25. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
26. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
[TBL] [Abstract][Full Text] [Related]
27. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
Head SJ; Mack MJ; Holmes DR; Mohr FW; Morice MC; Serruys PW; Kappetein AP
Eur J Cardiothorac Surg; 2012 Mar; 41(3):535-41. PubMed ID: 22219412
[TBL] [Abstract][Full Text] [Related]
28. Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
Kang SH; Park KH; Choi DJ; Park KW; Chung WY; Lim C; Kim KB; Kim HS
Am J Cardiol; 2010 Feb; 105(3):343-51. PubMed ID: 20102946
[TBL] [Abstract][Full Text] [Related]
29. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).
Ix JH; Mercado N; Shlipak MG; Lemos PA; Boersma E; Lindeboom W; O'Neill WW; Wijns W; Serruys PW
Am Heart J; 2005 Mar; 149(3):512-9. PubMed ID: 15864241
[TBL] [Abstract][Full Text] [Related]
30. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization.
Buszman PE; Kiesz SR; Bochenek A; Peszek-Przybyla E; Szkrobka I; Debinski M; Bialkowska B; Dudek D; Gruszka A; Zurakowski A; Milewski K; Wilczynski M; Rzeszutko L; Buszman P; Szymszal J; Martin JL; Tendera M
J Am Coll Cardiol; 2008 Feb; 51(5):538-45. PubMed ID: 18237682
[TBL] [Abstract][Full Text] [Related]
31. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
Shaw JA; Andrianopoulos N; Duffy S; Walton AS; Clark D; Lew R; Sebastian M; New G; Brennan A; Reid C; Ajani AE;
Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?
Mehta RH; Lopes RD; Ballotta A; Frigiola A; Sketch MH; Bossone E; Bates ER
Am Heart J; 2010 Jan; 159(1):141-7. PubMed ID: 20102880
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era.
Kimura T; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Ehara N; Taniguchi R; Doi T; Nishiyama K; Ozasa N; Saito N; Hoshino K; Mitsuoka H; Abe M; Toma M; Tamura T; Haruna Y; Imai Y; Teramukai S; Fukushima M; Kita T
Circulation; 2008 Sep; 118(14 Suppl):S199-209. PubMed ID: 18824755
[TBL] [Abstract][Full Text] [Related]
34. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.
Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM
Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244
[TBL] [Abstract][Full Text] [Related]
35. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).
Rodriguez AE; Baldi J; Fernández Pereira C; Navia J; Rodriguez Alemparte M; Delacasa A; Vigo F; Vogel D; O'Neill W; Palacios IF;
J Am Coll Cardiol; 2005 Aug; 46(4):582-8. PubMed ID: 16098419
[TBL] [Abstract][Full Text] [Related]
36. Favorable long-term survival in patients undergoing stent PCI of unprotected left main coronary artery compared to predicted short-term prognosis of CABG estimated by EuroSCORE: clinical determinants of long-term outcome.
Lehmann R; Spyridopoulos I; Kremer J; Zeiher AM; Schächinger V; Fichtlscherer S
J Interv Cardiol; 2009 Aug; 22(4):311-9. PubMed ID: 19689656
[TBL] [Abstract][Full Text] [Related]
37. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study).
Sarno G; Garg S; Onuma Y; Gutiérrez-Chico JL; van den Brand MJ; Rensing BJ; Morel MA; Serruys PW;
Am J Cardiol; 2010 Nov; 106(10):1369-75. PubMed ID: 21059423
[TBL] [Abstract][Full Text] [Related]
38. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.
White HD; Assmann SF; Sanborn TA; Jacobs AK; Webb JG; Sleeper LA; Wong CK; Stewart JT; Aylward PE; Wong SC; Hochman JS
Circulation; 2005 Sep; 112(13):1992-2001. PubMed ID: 16186436
[TBL] [Abstract][Full Text] [Related]
39. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH
N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353
[TBL] [Abstract][Full Text] [Related]
40. Comparison of drug eluting stent implantation with coronary artery bypass surgery in the treatment of patients with chronic total occlusion and multiple vessel disease.
Liu W; Ma CS; Kang JP; Du X; Chen F; Zhou YJ; Lü SZ; Huang FJ; Gu CX; Zhu XL
Chin Med J (Engl); 2011 Apr; 124(8):1169-74. PubMed ID: 21542990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
